The cytotoxicity of methyl protodioscin against human cancer cell lines in vitro

Cancer Investigation

Volumn 21, Issue 3, 2003, Pages 389-393

  Hu, Ke ^a   Yao, Xinsheng ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cytotoxicity; Dioscorea collettii var. hypoglauca; Methyl protodioscin; NCI's anticancer drug screen; NSC 698790

Indexed keywords

METHYL PROTODIOSCIN; NSC 698790; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CHINESE HERB; COLON CANCER; CYTOTOXICITY; DIOSCOREACEAE; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY TUMOR; LEUKEMIA CELL LINE; PRIORITY JOURNAL; RHIZOME; SOLID TUMOR; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM NEOPLASMS; COLONIC NEOPLASMS; DIOSGENIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LEUKEMIA; LUNG NEOPLASMS; MALE; SAPONINS; TUMOR CELLS, CULTURED;

EID: 0041857788     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120018230     Document Type: Article

References (19)

1. Kobayashi, H.; Namikoshi, M.; Yoshimoto, T.; Yokochi, T. A screening method for antimitotic and antifungal substances using conidia of Pyricularia oryzae, modification and application to tropical marine fungi. J. Antibiotics 1996, 49, 873-879.
2. Hu, K.; Dong, A.J.; Yao, X.S.; Kobayashi, H.; Iwasaki, S. Antineoplastic agents; I. Three spirostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca. Planta Med. 1996, 62, 573-575.
3. Hu, K.; Dong, A.J.; Yao, X.S.; Kobayashi, H.; Iwasaki, S. Antineoplastic agents; II. Four furostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca. Planta Med. 1997, 63, 161-165.
4. Hu, K.; Dong, A.J.; Yao, X.S.; Kobayashi, H.; Iwasaki, S. A furostanol glycoside from rhizomes of Dioscorea collettii var. hypoglauca. Phytochemistry 1997, 44, 1339-1342.
5. Hu, K.; Dong, A.J.; Kobayshi, H.; Iwasaki, S.; Jing, Y.K.; Yao, X.S. A new pregnane glycoside from Dioscorea collettii var. hypoglauca. J. Nat. Prod. 1999, 62, 299-301.
6. Hu, K.; Kobayashi, H.; Dong, A.J.; Iwasaki, S.; Yao, X.S. A new pregnane glycoside from Dioscorea collettii var. hypoglauca. Chin. Chem. Lett. 1998, 9, 739-742.
7. Boyd, M.R. Status of the NCI preclinical antitumor drug discovery screen. In Cancer: Principles and Practice of Oncology Updates; De Vita, V.T., Jr., Hellman, S., Rosenberg, S.A., Eds.; 1989; 1-12.
8. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistics, D.; Hose, C.; Langley, J.; Crenise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl Cancer Inst. 1991, 83, 757-766.
9. Grever, M.R.; Schepartz, S.A.; Chabner, B.A. The National Cancer Institute cancer drug discovery and development program. Semin. Oncol. 1992, 19, 622-638.
10. Alley, M.C.; Scudiero, D.A.; Monks, A.P.; Hursey, M.L.; Czerwinski, M.J. ; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1998, 48, 589-601.
11. Skehan, P.; Storeng, R.; Scudiero, D.A.; Monks, A.P.; McMahan, J.; Vistica, D.T.; Warren, J.T.; Buokeach, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl Cancer Inst. 1990, 82, 1107-1112.
12. Rubinstein, L.V.; Shoemaker, R.H.; Paull, K.D.; Monks, R.M.; Tesini, S.; Skehan, P.; Scudiero, D.A.; Menks, A.P.; Boyd, M.R. Comparison of in vitro anticancer drug screening data generated with a tertrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl Cancer Inst. 1990, 82, 1113-1118.
13. Paull, K.D.; Shoemaker, R.H.; Hodes, L.; Monks, A.P.; Scudiero, D.A.; Rubinstein, L.V.; Plowman, J.; Boyd, M.R. Display and analysis of pattern of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl Cancer Inst. 1989, 81, 1088-1092.
14. Weinstein, J.N.; Kohn, K.W.; Grever, M.R.; Viswanadhan, V.N.; Rubinstein, L.V.; Monks, A.P.; Scudiero, D.A.; Welch, L.; Koutsoukos, A.D.; Chiause, A.-J. ; Paull, K.D. Neural computing in cancer drug development: predicting mechanism of action. Science 1992, 258, 447-451.
15. Boyd, M.R.; Paull, K.D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995, 34, 91-109.
16. Bates, S.E.; Fojo, A.T.; Weinstein, J.N.; Myers, T.G.; Alvarez, M.; Paull, K.D.; Chabuer, B.A. Molecular targets in the National Cancer Institute drug screen. J. Cancer Res. Clin. Oncol. 1995, 121, 495-500.
17. Monks, A.P.; Scudiero, D.A.; Johnson, G.S.; Paull, K.D.; Sausville, K.A. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anti-Cancer Drug Des. 1997, 12, 533-541.
18. Weinstein, J.N.; Myers, T.G.; O'Connor, P.M.; Friend, S.H.; Fernace, A.J.; Kohn, K.W.; Fojo, T.; Bates, S.E.; Rubinstein, L.V.; Anderson, N.L.; Buolamwni, J.K.; van Osdel, W.W.; Monks, A.P.; Scudiero, D.A.; Sausville, E.A.; Zaharevitz, D.W.; Bunow, E.; Viswanadhan, V.N.; Johnson, G.S.; Wittes, R.E.; Paull, K.D. An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275, 343-349.
19. Hollingshead, M.G.; Alley, M.C.; Camalier, R.F.; Abbott, B.J.; Mayo, J.G.; Malspeis, L.; Grever, M.R. In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1995, 57, 131-141.